Therefore, direct or indirect stimulation of GLP-1 receptors is currently being discussed as a therapeutic option for BED, comorbid depression in obesity, or in psychopharmacological treatments associated with weight gain [142]. The gene discussed is GLP1R; the disease is depressive disorder.